Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye Djimde | Gabon, Burkina Faso, Mali, Niger<\/p>\n\n\n\n
Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye…<\/p>\n","protected":false},"author":1,"featured_media":2383,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[39],"tags":[],"class_list":["post-2380","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-project-en"],"uagb_featured_image_src":{"full":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false],"thumbnail":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV-150x150.png",150,150,true],"medium":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV-300x147.png",300,147,true],"medium_large":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false],"large":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false],"1536x1536":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false],"2048x2048":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false]},"uagb_author_info":{"display_name":"admin","author_link":"https:\/\/www.mrtc-parasito.org\/PMRTC\/author\/admin\/"},"uagb_comment_info":0,"uagb_excerpt":"Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye...","rttpg_featured_image_url":{"full":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false],"landscape":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false],"portraits":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false],"thumbnail":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV-150x150.png",150,150,true],"medium":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV-300x147.png",300,147,true],"large":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false],"1536x1536":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false],"2048x2048":["https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-content\/uploads\/2025\/06\/PfTBV.png",570,280,false]},"rttpg_author":{"display_name":"admin","author_link":"https:\/\/www.mrtc-parasito.org\/PMRTC\/author\/admin\/"},"rttpg_comment":0,"rttpg_category":"Project<\/a>","rttpg_excerpt":"Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye...","_links":{"self":[{"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/posts\/2380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/comments?post=2380"}],"version-history":[{"count":1,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/posts\/2380\/revisions"}],"predecessor-version":[{"id":2384,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/posts\/2380\/revisions\/2384"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/media\/2383"}],"wp:attachment":[{"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/media?parent=2380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/categories?post=2380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mrtc-parasito.org\/PMRTC\/wp-json\/wp\/v2\/tags?post=2380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}